Table 2.

Frequent adverse events with an overall incidence ≥10% (Intent-to-Treat population, N = 675)

Preferred term	n (%)
Nausea	144 (21.3)
Diarrhoea	98 (14.5)
Nasopharyngitis	83 (12.3)
Vomiting	69 (10.2)